Early research (Phase 1)Study completedNCT00474669What this trial is testingA Phase I Study of Intraperitoneal Hyperthermic DocetaxelWho this might be right forOvarian Carcinoma University of Louisville 30
Testing effectiveness (Phase 2)Study completedNCT03895970What this trial is testingLenvatinib Combined Pembrolizumab in Advanced Hepatobiliary TumorsWho this might be right forLiver Neoplasm Malignant PrimaryCholangiocarcinomaCombinational Immunotherapy+1 more Peking Union Medical College Hospital 32
Testing effectiveness (Phase 2)Ended earlyNCT00020969What this trial is testingArsenic Trioxide in Treating Patients With Myelodysplastic SyndromesWho this might be right forLeukemiaMyelodysplastic SyndromesMyelodysplastic/Myeloproliferative Neoplasms CTI BioPharma
Not applicableLooking for participantsNCT06371274What this trial is testingA Study on the Efficacy and Safety of Oral All-trans Retinoic Acid Combined With Toripalimab in TNBC.Who this might be right forTriple-negative Breast Cancer First Affiliated Hospital of Zhejiang University 29
Testing effectiveness (Phase 2)Study completedNCT04835896What this trial is testingStudy of M7824 and Paclitaxel Combination as a Second-line Treatment in Patients With Recurrent/Metastatic Gastric CancerWho this might be right forRecurrent/Metastatic Gastric Cancer Yonsei University 49
Not applicableUnknownNCT05895942What this trial is testingExploring the Molecular Mechanism Based on KIT MutationWho this might be right forGIST Xijing Hospital 190
Not applicableNot Yet RecruitingNCT06785870What this trial is testingEVAluation of Erythrocytosis PRospEctive Cohort STudyWho this might be right forErythrocytosisPolycythemiaPolycythemia Secondary+5 more Cyrus Hsia 1,500
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07649980What this trial is testingBecotatug Vedotin Plus Pucotenlimab for Advanced Biliary Tract Cancer, Phase IIWho this might be right forBiliary Tract Cancer (BTC)EGFR-positive Advanced Biliary Tract Carcinoma HuiKai Li 30
Not applicableStudy completedNCT00410579What this trial is testingPatient-Reported Outcomes in Long-Term Survivors of Colon and Rectal CancersWho this might be right forColorectal CancerFatigueLong-term Effects Secondary to Cancer Therapy in Adults+2 more NSABP Foundation Inc 744
Early research (Phase 1)UnknownNCT05675462What this trial is testingOncolytic Virotherapy Plus PD-1 Inhibitor and Lenvatinib as Second-line or Later Therapy in Patients With Advanced Hepatocellular CarcinomaWho this might be right forHepatocellular Carcinoma Fudan University 25
Testing effectiveness (Phase 2)UnknownNCT04572542What this trial is testingCamrelizumab Combined With Apatinib Mesylate Tablets and Nab-paclitaxel in the Second-line Treatment of Advanced Gastric CancerWho this might be right forLocally Advanced or Metastatic Gastric Adenocarcinoma The First Affiliated Hospital of Xiamen University 46
Testing effectiveness (Phase 2)Looking for participantsNCT07559760What this trial is testingNew Second-Line Combo Therapy for MSS Metastatic Colorectal CancerWho this might be right forMetastatic Colorectal Cancer The First Hospital of Jilin University 30
Not applicableStudy completedNCT03433560What this trial is testingAn Observational Study to Evaluate the Safety and Efficacy of Pegfilgrastim (Neulasta®)Who this might be right forBreast Cancer FemaleBreast Neoplasm Female Kyowa Kirin Korea Co., Ltd. 1,300
Testing effectiveness (Phase 2)Study completedNCT00305786What this trial is testingGemcitabine and Oxaliplatin as Second-Line Therapy in Treating Patients With Stage III or Stage IV Non-Small Cell Lung CancerWho this might be right forLung Cancer University of Miami 30
Testing effectiveness (Phase 2)Study completedNCT02716766What this trial is testingStudy of SECOX Versus Sorafenib as First-Line Treatment in Patients With Advanced Hepatocellular Carcinoma (HCC)Who this might be right forCarcinoma, HepatocellularSecondary The University of Hong Kong 46
Testing effectiveness (Phase 2)Study completedNCT01298570What this trial is testingRegorafenib+FOLFIRI Versus Placebo+FOLFIRI as 2nd Line Tx in Metastatic Colorectal CancerWho this might be right forColorectal Cancer Metastatic UNC Lineberger Comprehensive Cancer Center 181
Not applicableUnknownNCT03413865What this trial is testingTelemedicine Clinic for Prostate Cancer PatientsWho this might be right forCancer, Treatment-Related Grand River Hospital 80
Testing effectiveness (Phase 2)Study completedNCT00352001What this trial is testingLenalidomide and Azacitidine in Treating Patients With Advanced Myelodysplastic SyndromesWho this might be right forLeukemiaMyelodysplastic Syndromes Mikkael Sekeres MD 37
Large-scale testing (Phase 3)Looking for participantsNCT07062965What this trial is testingLearn About the Study Medicine Called PF-07248144 in Combination With Fulvestrant in People With HR-positive, HER2-negative Advanced or Metastatic Breast Cancer Who Progressed After a Prior Line of Treatment.Who this might be right forBreast Cancer Pfizer 400
Early research (Phase 1)Study completedNCT01300572What this trial is testingYttrium-90 Anti-CD45 Monoclonal Antibody BC8 Followed by Donor Stem Cell Transplant in Treating Patients With High-Risk AML, ALL, or MDSWho this might be right forChronic Myelomonocytic LeukemiaPreviously Treated Myelodysplastic SyndromeRecurrent Adult Acute Lymphoblastic Leukemia+3 more Fred Hutchinson Cancer Center 16